Canadian Imperial Bank of Commerce (TSX:CM)

CTI BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Market Capitalization	92,821	82,280	45,216	55,971	67,623	44,323
Market Cap Growth	35.63%	81.97%	-19.21%	-17.23%	52.57%	-11.29%
Last Close Price	99.36	84.32	44.95	53.42	61.80	39.10
PE Ratio	12.49	12.01	9.55	9.25	10.78	12.08
PS Ratio	3.65	3.49	2.12	2.69	3.41	2.73
PB Ratio	1.50	1.39	0.85	1.11	1.48	1.07
Debt / Equity Ratio	4.67	4.44	4.28	4.05	3.92	4.06
Return on Equity (ROE)	13.36%	12.76%	9.73%	12.98%	14.79%	9.49%
Return on Assets (ROA)	0.75%	0.71%	0.53%	0.70%	0.80%	0.53%
Earnings Yield	8.10%	8.65%	11.06%	11.11%	9.51%	8.55%
FCF Yield	-27.32%	-29.74%	-13.06%	-94.52%	-76.44%	-49.94%
Dividend Yield	3.90%	4.27%	7.65%	6.12%	4.72%	7.44%
Payout Ratio	47.73%	41.42%	45.21%	47.78%	41.20%	67.84%
Buyback Yield / Dilution	-1.86%	-2.78%	-1.16%	-0.59%	-0.93%	-0.13%
Total Shareholder Return	2.02%	1.49%	6.49%	5.53%	3.79%	7.32%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.